The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Spreading of Neurodegenerative Pathology via Neuron-to-Neuron Transmission of -Amyloid
Open accessAbstract
Alzheimer's disease (AD) is the major cause of dementia. During the development of AD, neurofibrillary tangles progress in a fixed pattern, starting in the transentorhinal cortex followed by the hippocampus and cortical areas. In contrast, the deposition of β-amyloid (Aβ) plaques, which are the other histological hallmark of AD, does not follow the same strict spatiotemporal pattern, and it correlates poorly with cognitive decline. Instead, soluble Aβ oligomers have received increasing attention as probable inducers of pathogenesis. In this study, we use microinjections into electrophysiologically defined primary hippocampal rat neurons to demonstrate the direct neuron-to-neuron transfer of soluble oligomeric Aβ. Additional studies conducted in a human donor-acceptor cell model show that this Aβ transfer depends on direct cellular connections. As the transferred oligomers accumulate, acceptor cells gradually show beading of tubulin, a sign of neurite damage, and gradual endosomal leakage, a sign of cytotoxicity. These observations support that intracellular Aβ oligomers play a role in neurodegeneration, and they explain the manner in which Aβ can drive disease progression, even if the extracellular plaque load is poorly correlated with the degree of cognitive decline. Understanding this phenomenon sheds light on the pathophysiological mechanism of AD progression. Additional elucidation will help uncover the detailed mechanisms responsible for the manner in which AD progresses via anatomical connections and will facilitate the development of new strategies for stopping the progression of this incapacitating disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several studies have shown that both extracellular free Aβ and Aβ-contained EVs play a role in the progression of AD pathology [136–140].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [140]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There have been several proposed mechanisms by which this process occurs including exosomes and direct transmission of Aβ42 from neuron to neuron that are directly connected by tunneling nanotubes [22].”
From The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates (2020) · cites this paper as [22]
Experimental — accuracy not yet measuredIn the citing paper
“Some studies have indicated that amyloid pathology might be gradually transmitted through connected brain structures [10, 69, 84, 96], by mechanisms that are still under investigation.”
From Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology (2023) · cites this paper as [84]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Dynasore, a Cell-Permeable Inhibitor of Dynamin
Macia, E., Ehrlich, M., Massol, R., Boucrot, E., Brunner, C., & Kirchhausen, T. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.04.002 · Cited by 1,958
Intracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Transmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Alzheimer’s disease β-amyloid peptides are released in association with exosomes
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603838103 · Cited by 1,343
Cited by
Sorted by citations
Items 101–200 of 244
Marciniuk, K., Taschuk, R., & Napper, S. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/473706 · Cited by 39
Konstantinidis, E., Portal, B., Mothes, T., Beretta, C., Lindskog, M., & Erlandsson, A. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02687-5 · Cited by 35
Mechanisms of protein homeostasis in health, aging and disease
Goloubinoff, P. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14306 · Cited by 35
Wang, R., Xu, X., Hao, Z., Zhang, S., Wu, D., Sun, H., Mu, C., Ren, H., & Wang, G. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00395-4 · Cited by 35
Nanomedicines for Alzheimer's disease: Therapies based on pathological mechanisms
Cheng, G., Xie, A., Yan, Z., Zhu, X., Song, Y., & Chen, T. (2023) · Brain‐X · doi:10.1002/brx2.27 · Cited by 35
Delineating the membrane-disrupting and seeding properties of the TDP-43 amyloidogenic core
Liu, G. C.-H., Chen, B. P., Ye, T.-J., Wang, C., Chen, W., Lee, H., Chan, S. I., & Huang, J. J. (2013) · Chemical Communications · doi:10.1039/c3cc46762g · Cited by 34
The Role of Extracellular Vesicles in Systemic Lupus Erythematosus
Zheng, C., Xie, L., Qin, H., Liu, X., Chen, X., Lv, F., Wang, L., Zhu, X., & Xu, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.835566 · Cited by 33
“Prion-like” seeding and propagation of oligomeric protein assemblies in neurodegenerative disorders
Zampar, S., Gregorio, S. E. D., Grimmer, G., Watts, J. C., & Ingelsson, M. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1436262 · Cited by 39
Intracellular Localization of Amyloid-β Peptide in SH-SY5Y Neuroblastoma Cells
Zheng, L. P., Calvo‐Garrido, J., Hallbeck, M., Hultenby, K. R., Marcusson, J. O., Cedazo-Mı́nguez, Á., & Terman, A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122455 · Cited by 33
Self-citationAβ seeds and prions: How close the fit?
Rasmussen, J., Jucker, M., & Walker, L. C. (2017) · Prion · doi:10.1080/19336896.2017.1334029 · Cited by 33
Intercellular communication in the brain through a dendritic nanotubular network
Chang, M., Krüssel, S., Parajuli, L. K., Kim, J., Lee, D., Merodio, A., Kwon, J., Okabe, S., & Kwon, H. (2025) · Science · doi:10.1126/science.adr7403 · Cited by 32
Sang, J. C., Lee, J., Dear, A. J., De, S., Meisl, G., Thackray, A. M., Bujdoso, R., Knowles, T. P. J., & Klenerman, D. (2019) · Chemical Science · doi:10.1039/c8sc05627g · Cited by 28
Pathogenic and protective roles of extracellular vesicles in neurodegenerative diseases
Takeuchi, T. (2020) · The Journal of Biochemistry · doi:10.1093/jb/mvaa131 · Cited by 29
Alzheimer's Disease and Prion Protein
Zhou, J. (2013) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2013.v2.2.35 · Cited by 31
Protein aggregation and prionopathies
Renner, M. L., & Melki, R. (2014) · Pathologie Biologie · doi:10.1016/j.patbio.2014.01.003 · Cited by 31
Comparison of Amyloid β and Tau Spread Models in Alzheimer’s Disease
Kim, H., Lee, P., Seo, S. W., Roh, J. H., Oh, M., Oh, J. S., Oh, S. J., Kim, J. S., & Jeong, Y. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy311 · Cited by 32
Yang, W., Ma, K., Qian, Y., Zhang, J.-S., Feng, G.-F., Shi, L., Zhang, Z., & Liu, Z. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.04.013 · Cited by 29
Christensen, D. Z., Hüttenrauch, M., Mitkovski, M., Pradier, L., & Wirths, O. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00139 · Cited by 29
Hochstrasser, T., Hohsfield, L. A., Sperner‐Unterweger, B., & Humpel, C. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23126 · Cited by 27
Pluta, R. M., & Ułamek-Kozioł, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-05542-4_4 · Cited by 51
Sackmann, C., & Hallbeck, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-63398-6 · Cited by 27
Self-citationExtracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions
Choi, H. K., Chen, M., Goldston, L. L., & Lee, K.-B. (2024) · Nano Convergence · doi:10.1186/s40580-024-00426-5 · Cited by 26
Intraneuronal β‐amyloid and its interactions with proteins and subcellular organelles
Penke, B., Tóth, A. M., Földi, I., Szűcs, M., & Janáky, T. (2012) · Electrophoresis · doi:10.1002/elps.201200297 · Cited by 26
Prelysosomal Compartments in the Unconventional Secretion of Amyloidogenic Seeds
Madsen, H. B., & Vilhardt, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010227 · Cited by 26
The Quest for Cellular Prion Protein Functions in the Aged and Neurodegenerating Brain
Gavı́n, R., Lidón, L., Ferrer, I., & del Rı́o, J. A. (2020) · Cells · doi:10.3390/cells9030591 · Cited by 25
Sackmann, V., Ansell, A., Sackmann, C., Lund, H., Harris, R. A., Hallbeck, M., & Nilsberth, C. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.08.022 · Cited by 25
Self-citationPrion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis
Bräuer, S., Zimyanin, V. L., & Hermann, A. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1851-y · Cited by 29
Ageing promotes microglial accumulation of slow-degrading synaptic proteins
Guldner, I. H., Wagner, V., Losada, P. M., Shi, S. M., Golub, S. W., Hevler, J. F., Chen, K. S., Meese, B. T., Ghoochani, A., Pulido, E. H., et al. (2026) · Nature · doi:10.1038/s41586-025-09987-9 · Cited by 33
Agholme, L., Nath, S., Domert, J., Marcusson, J. O., Kågedal, K., & Hallbeck, M. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.11.001 · Cited by 25
Self-citationInfectivity versus Seeding in Neurodegenerative Diseases Sharing a Prion-Like Mechanism
Fernández‐Borges, N., Eraña, H., Elezgarai, S. R., Harrathi, C., Gayosso, M., & Castilla, J. (2013) · International Journal of Cell Biology · doi:10.1155/2013/583498 · Cited by 26
Eraña, H., Venegas, V., Charco, J. M., & Castilla, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.166 · Cited by 26
Neuron-to-Neuron Transmission of Neurodegenerative Pathology
Hallbeck, M., Nath, S., & Marcusson, J. O. (2013) · The Neuroscientist · doi:10.1177/1073858413494270 · Cited by 24
Self-citationFeller, B., Fallon, A., Luo, W., Nguyen, P. T., Shlaifer, I., Lee, A. K., Chofflet, N., Yi, N., Khaled, H., Karkout, S., et al. (2023) · Cells · doi:10.3390/cells12071083 · Cited by 22
The role of astrocytes in prion-like mechanisms of neurodegeneration
Smethurst, P., Franklin, H., Clarke, B. E., Sidle, K. C. L., & Patani, R. (2021) · Brain · doi:10.1093/brain/awab366 · Cited by 25
Exosomes as Possible Spread Factor and Potential Biomarkers in Alzheimer'S Disease: Current Concepts
Pluta, R. M., Ułamek-Kozioł, M., Januszewski, S., & Czuczwar, S. J. (2018) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0034 · Cited by 25
George, S., Rönnbäck, A., Gouras, G. K., Petit, G. H., Grueninger, F., Winblad, B., Graff, C., & Brundin, P. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-17 · Cited by 23
Raghavan, A., Kashyap, R., Sreedevi, P. R., Jos, S., Chatterjee, S., Alex, A., D’Souza, M. N., Giridharan, M., Muddashetty, R. S., Manjithaya, R. R., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110565 · Cited by 23
Self-citationPotential common pathogenesis of several neurodegenerative diseases
Fan, T., Peng, J., Liang, H., Chen, W., Wang, J., & Xu, R. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01054 · Cited by 29
Koch, Y., Helferich, A. M., Steinacker, P., Oeckl, P., Walther, P., Weishaupt, J. H., Danzer, K. M., & Otto, M. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.04.008 · Cited by 21
Mechanisms of protein misfolding: Novel therapeutic approaches to protein-misfolding diseases
Salahuddin, P., Siddiqi, M. K., Khan, S., Abdelhameed, A. S., & Khan, R. H. (2016) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2016.06.046 · Cited by 23
Prions: A Piece of the Puzzle?
Lahiri, D. K. (2012) · Science · doi:10.1126/science.337.6099.1172-a · Cited by 22
Ma, C., Wang, J., Zhang, J., Chen, K., Li, X., Shu, N., Chen, Y., Liu, Z., & Zhang, Z. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0224-5 · Cited by 21
Chopra, G., Shabir, S., Yousuf, S., Kauts, S., Bhat, S. A., Mir, A. H., & Singh, M. P. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03042-8 · Cited by 24
Endocytic pathways of pathogenic protein aggregates in neurodegenerative diseases
Hivare, P., Mujmer, K., Swarup, G., Gupta, S. K., & Bhatia, D. D. (2023) · Traffic · doi:10.1111/tra.12906 · Cited by 24
Borbély, E., Horváth, J., Furdan, S., Bozsó, Z., Penke, B., & Fülöp, L. (2014) · BioMed Research International · doi:10.1155/2014/345305 · Cited by 21
Lysosomal Enzyme Glucocerebrosidase Protects against Aβ1-42 Oligomer-Induced Neurotoxicity
Choi, S., Kim, D., Kam, T., Yun, S., Kim, S., Park, H., Hwang, H., Pletniková, O., Troncoso, J. C., Dawson, V. L., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143854 · Cited by 21
Zhang, C., Gu, Z., Shen, L., Liu, X., & Lin, H. (2019) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201020666190204141046 · Cited by 20
Membrane interaction to intercellular spread of pathology in Alzheimer’s disease
Valappil, D. K., Mini, N. J., Dilna, A., & Nath, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.936897 · Cited by 19
Self-citationNakagawa, Y., & Yamada, S. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01234-3 · Cited by 20
Counil, H., & Krantic, S. M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191237 · Cited by 20
Reduced retromer function results in the accumulation of amyloid-beta oligomers
Ansell-Schultz, A., Reyes, J. F., Samuelsson, M., & Hallbeck, M. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.09.003 · Cited by 18
Self-citationSackmann, C., Sackmann, V., & Hallbeck, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00540 · Cited by 21
Self-citationPerforin Promotes Amyloid Beta Internalisation in Neurons
Lana, E., Khanbolouki, M., Degavre, C., Samuelsson, E., Åkesson, E., Winblad, B. G., Alici, E., Lithner, C. U., & Behbahani, H. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9685-9 · Cited by 18
Key Points Concerning Amyloid Infectivity and Prion-Like Neuronal Invasion
Espargaró, A., Busquets, M. A., Estelrich, J., & Sabaté, R. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00029 · Cited by 18
Berntsson, E., Vosough, F., Svantesson, T., Pansieri, J., Iashchishyn, I. A., Ostojić, L., Dong, X., Paul, S., Jarvet, J., Roos, P. M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-29901-5 · Cited by 16
The Role of Clearance in Neurodegenerative Diseases
Brennan, G. S., Thompson, T., Oliveri, H., Rognes, M. E., & Goriely, A. (2023) · SIAM Journal on Applied Mathematics · doi:10.1137/22m1487801 · Cited by 20
Chuang, W.-H., Chou, Y.-T., Chen, Y.-H., Kuo, T.-H., Liaw, W., Lu, T., Kao, C.-F., & Wang, Y. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00348 · Cited by 17
Convergence of Synapses, Endosomes, and Prions in the Biology of Neurodegenerative Diseases
Gouras, G. K. (2013) · International Journal of Cell Biology · doi:10.1155/2013/141083 · Cited by 17
Emerging links between cell competition and Alzheimer's disease
Coelho, D. S., & Moreno, E. (2019) · Journal of Cell Science · doi:10.1242/jcs.231258 · Cited by 19
Liu, X., Wang, H., Tian, X., Luo, Y., Ma, M., Zheng, Z., Wang, Y., Shi, F., Wang, Q., Xu, Z. F., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03488-2 · Cited by 17
Doherty, G. H., Holiday, A., Malekizadeh, Y., Manolescu, C., Duncan, S., Flewitt, I., Hamilton, K., MacLeod, B., Ainge, J. A., & Harvey, J. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15733 · Cited by 16
Iturria‐Medina, Y., Hachinski, V., & Evans, A. C. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000497 · Cited by 18
Intertwined Pathologies of Amyloid-β and Metal Ions in Alzheimer’s Disease: Metal–Amyloid-β
Nam, G., & Lim, M. H. (2019) · Chemistry Letters · doi:10.1246/cl.190281 · Cited by 16
Tremblay, C., Serrano, G. E., Intorcia, A. J., Mariner, M., Sue, L. I., Arce, R. A., Atri, A., Adler, C. H., Belden, C. M., Shill, H. A., et al. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac042 · Cited by 15
Spreading of Pathology in Alzheimer’s Disease
Lv, Z., Tan, C., Yu, J., & Tan, L. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9765-2 · Cited by 15
Ochoa, J. F., Alonso, J. F., Duque, J. E., Tobón, C., Mañanas, M. Á., Lopera, F. J., & Hernández, A. M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160803 · Cited by 12
Entropic Bristles Tune the Seeding Efficiency of Prion-Nucleating Fragments
Michiels, E., Liu, S., Gallardo, R. U., Louros, N. N., Mathelié‐Guinlet, M., Dufrêne, Y. F., Schymkowitz, J. W. H., Vorberg, I. M., & Rousseau, F. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.098 · Cited by 15
Cell-free amplification of prions: Where do we stand?
Cazzaniga, F. A., Luca, C. M. G. D., Bistaffa, E., Consonni, A., Legname, G., Giaccone, G., & Moda, F. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.005 · Cited by 14
Luyckx, T., Grootaert, C., Monge‐Morera, M., Delcour, J. A., Rousseau, F., Schymkowitz, J. W. H., & Camp, J. V. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202101032 · Cited by 14
Zhang, W., Du, Y., Bai, M., Ye, X., Li, Z., & Miao, J. (2013) · Journal of Peptide Science · doi:10.1002/psc.2484 · Cited by 14
RetractedMa, K., Lv, J., Hu, X. D., Shi, L., Chang, K.-W., Chen, X., Qian, Y., Yang, W., & Qu, Q. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.04.019 · Cited by 14
Autoantibody-triggered podocyte membrane budding drives autoimmune kidney disease
Lahme, K., Sachs, W., Froembling, S., Loreth, D., Böttcher-Dierks, V., Neumann, K., Hann, F.-M., Arkan, N., Brehler, M., Reichelt, J., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.010 · Cited by 15
Liegro, C. M. D., Schiera, G., Schirò, G., & Liegro, I. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314622 · Cited by 16
Pryor, N. E., Moss, M. A., & Hestekin, C. N. (2014) · Electrophoresis · doi:10.1002/elps.201400012 · Cited by 13
Choi, Y., Kim, S.-M., Heo, Y., Lee, G., Kang, J. Y., & Yoon, D. S. (2020) · Nanotechnology · doi:10.1088/1361-6528/abba58 · Cited by 13
Ali, A., Holman, A. P., Rodriguez, A., Matveyenka, M., & Kurouski, D. (2024) · Protein Science · doi:10.1002/pro.5078 · Cited by 11
Animal models for prion-like diseases
Fernández‐Borges, N., Eraña, H., Venegas, V., Elezgarai, S. R., Harrathi, C., & Castilla, J. (2015) · Virus Research · doi:10.1016/j.virusres.2015.04.014 · Cited by 13
Cognitive erosion and its implications in Alzheimer’s disease
Mårdh, S. (2013) · Cited by 11
Stationary distribution of a stochastic Alzheimer's disease model
Hu, J., Zhang, Q., Meyer‐Baese, A., & Ye, M. (2020) · Mathematical Methods in the Applied Sciences · doi:10.1002/mma.6642 · Cited by 11
Tubulin‐Binding Region Modulates Cholesterol‐Triggered Aggregation of Tau Proteins
Ali, A., Matveyenka, M., Pickett, D. N., Rodriguez, A., & Kurouski, D. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16294 · Cited by 10
Detection and Quantification of Tunneling Nanotubes Using 3D Volume View Images
Valappil, D. K., Raghavan, A., & Nath, S. (2022) · Journal of Visualized Experiments · doi:10.3791/63992 · Cited by 10
Self-citationAnzalone, A., Annibale, P., & Gratton, E. (2014) · Journal of Visualized Experiments · doi:10.3791/51794 · Cited by 10
Wesén, E. V., Lundmark, R., & Esbjörner, E. K. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00053 · Cited by 9
Eslamizade, M. J., Madjd, Z., Rasoolijazi, H., Saffarzadeh, F., Pirhajati, Aligholi, H., Janahmadi, M., & Mehdizadeh, M. (2016) · Europe PMC (PubMed Central) · Cited by 9
Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases
Yoshida, S., & Hasegawa, T. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105307 · Cited by 9
Mechanism of Cellular Formation and In Vivo Seeding Effects of Hexameric β-Amyloid Assemblies
Vrancx, C., Vadukul, D. M., Suelves, N., Contino, S., D’Auria, L., Perrin, F., Pesch, V. V., Hanseeuw, B. J., Quinton, L., & Kienlen‐Campard, P. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02567-8 · Cited by 9
Moreira, R., Mendonça, L. S., & de Almeida, L. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212288 · Cited by 7
Pourbadie, H. G., Naderi, N., Mirzapourdelavar, H., Hosseinzadeh, M., Mehranfard, N., Khodagholi, F., Janahmadi, M., & Motamedi, F. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.11.032 · Cited by 8
Wei, P., Li, X., Gao, H., Chen, J., Lang, W., Zeng, L., Wei, D., Chen, M., Zhu, Q., & Jin, G. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105573 · Cited by 7
Berntsson, E., Paul, S., Vosough, F., Sholts, S. B., Jarvet, J., Roos, P. M., Barth, A., Gräslund, A., & Wärmländer, S. K. T. S. (2021) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5493 · Cited by 7
Modelling cerebrovascular pathology and the spread of amyloid beta in Alzheimer’s disease
Ahern, A., Thompson, T., Oliveri, H., Lorthois, S., & Goriely, A. (2025) · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rspa.2024.0548 · Cited by 8
Influencing factors and characterization methods of nanoparticles regulating amyloid aggregation
Li, L., Liu, J., Li, X., Tang, Y., Shi, C., Zhang, X., Cui, Y., Wang, L., & Xu, W. (2022) · Soft Matter · doi:10.1039/d1sm01704g · Cited by 5
Bitan, F. R. A. G. (2014) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608058525114020014 · Cited by 4
Han, F., Liu, X., Mailman, R. B., Huang, X., Liu, X., & Initiative, T. A. D. N. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.24.501309 · Cited by 4
Alzheimer’s disease and the mathematical mind
Thompson, T., Vigil, B. Z., & Young, R. S. K. (2024) · Brain Multiphysics · doi:10.1016/j.brain.2024.100094 · Cited by 3
Amyloid Beta Oligomers as Early Triggers of Neuronal Cytoskeleton Dysfunction in Alzheimer’s Disease
Gasca-Martínez, Y., Ontiveros‐Torres, M. Á., López-Gallegos, I., & Jarero-Basulto, J. J. (2026) · Pathophysiology · doi:10.3390/pathophysiology33010014 · Cited by 2
Dagar, S., Fernandez, A., Ramírez-Jarquín, U. N., López-Huerta, V. G., Mirza, E., Mohapatra, C., Zúñiga, I. H., Urban, N. T., Crynen, G. C., Tsaprailis, G., et al. (2026) · Science Advances · doi:10.1126/sciadv.aea1226 · Cited by 2
Advance reseach on strategies for the prevention of Alzheimer’s disease
Ni, J., Chen, P., Liu, Q., Zheng, Y., He, X., Song, G.-L., Ying, M., & Xu, X. (2013) · JOURNAL OF SHENZHEN UNIVERSITY SCIENCE AND ENGINEERING · doi:10.3724/sp.j.1249.2013.04331 · Cited by 2
The Role of Functional Networks in Neuropsychiatric Disorders
Canuet, L., Aoki, Y., Ishii, R., & Maestú, F. (2016) · Springer eBooks · doi:10.1007/978-3-319-32265-0_8 · Cited by 2
Bajić, V., Salhi, A., Lakota, K., Radovanović, A., Razali, R., Živković, L., Spremo‐Potparević, B., Uludağ, M., Tifratene, F., Motwalli, O., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271737 · Cited by 2
Metadata
- Authors
- Nath, S., Agholme, L., Kurudenkandy, F. R., Granseth, B., Marcusson, J., & Hallbeck, M.
- Affiliations
- Linköping University (SE)
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2012-06-27
- Volume
- 32
- Issue
- 26
- Pages
- 8767-8777
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6622335
- OpenAlex
- W2100421640
- Cited by
- 244
- References
- 50
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 14 · 2023: 11 · 2022: 15 · 2021: 16 · 2020: 17 · 2019: 17 · 2018: 19 · 2017: 17 · 2016: 28 · 2015: 13 · 2014: 25 · 2013: 27 · 2012: 5
- FWCI
- 15.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fondation pour la Recherche Médicale
- Vetenskapsrådet
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid-beta oligomers, neurodegeneration, hippocampal neurons, amyloid plaques, disease progression, cognitive decline
- MeSH terms
- Animals, Animals, Newborn, Cell Communication, Cell Differentiation, Cells, Cultured, Dendrites, Dose-Response Relationship, Drug, Endocytosis, Exocytosis, Female, Heterocyclic Compounds, 3-Ring, Hippocampus, Humans, Male, Membrane Glycoproteins, Microinjections, Nerve Degeneration, Nerve Tissue Proteins, Synaptic Transmission, Neuroblastoma, Neuroglia, Neurons, Peptide Fragments, Rhodamines, Tetrazolium Salts, Thiazoles, Time Factors, Transfection, Amyloid beta-Peptides, Rats, Sprague-Dawley, Patch-Clamp Techniques, Coculture Techniques, Neocortex, rab5 GTP-Binding Proteins, Microscopy, Electron, Transmission, Green Fluorescent Proteins, Rats, Lysosomal-Associated Membrane Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
